3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow cangrelor: new trials by email Literature Review of cangrelor trials Research Report on cangrelor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cangrelor Neonatal PK/PD and Safety Study Cangrelor - Partial Obstruction of Systemic to Pulmonary Artery Shunt, Complete Obstruction of Systemic to Pulmonary Artery Shunt | Phase 1 | Completed | Chiesi Farmaceutici S.p.A. | 22 | 2017-01-03 | 2023-02-15 |
| Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers cangrelor, moxifloxacin, placebo - Healthy | Phase 1 | Completed | The Medicines Company | 67 | 2008-06-01 | 2012-01-18 |
| Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor cangrelor - Healthy | Phase 1 | Completed | The Medicines Company | 40 | 2005-03-01 | 2011-08-16 |
The Medicines Company (2) · Chiesi Farmaceutici S.p.A. (1)
United States (3)
Steven Steinhubl, MD (1) · Thomas Diacovo, MD (1)
2016 (1)